awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q57298238-02B962BE-3327-4D7A-ADA8-812CA5E172A1
Q57298238-02B962BE-3327-4D7A-ADA8-812CA5E172A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57298238-02B962BE-3327-4D7A-ADA8-812CA5E172A1
Drug holiday in patients with polycystic liver disease treated with somatostatin analogues
P2860
Q57298238-02B962BE-3327-4D7A-ADA8-812CA5E172A1
BestRank
Statement
http://www.wikidata.org/entity/statement/Q57298238-02B962BE-3327-4D7A-ADA8-812CA5E172A1
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
36d55ac9ee8efb38ff4c1e92d83cd9208b13f2fc
P2860
Rationale and design of the DIPAK 1 study: a randomized controlled clinical trial assessing the efficacy of lanreotide to Halt disease progression in autosomal dominant polycystic kidney disease.